Presented by Jeannie Grubbs, PharmD. Breakfast will be provided. Attendees will be admitted on a first-come basis. This presentation will discuss the ongoing burden and shifting epidemiology of pneumococcal disease in adults, review the robust clinical trial program for an option to help address IPD in adults, and highlight the 2024 CDC recommendations for adult pneumococcal disease. Supported by Merck.